Real-world evidence on first-line treatment for metastatic renal cell carcinoma with non-clear cell and sarcomatoid histologies: are sunitinib and pazopanib interchangeable?

INTRODUCTION: Non-clear cell renal cell carcinoma (nccRCC) and sarcomatoid renal cell carcinoma (sRCC) are underrepresented in clinical trials. Treatment approaches are frequently extrapolated from data of clear cell renal cell carcinoma, in which pazopanib is non-inferior to sunitinib. We aim to co...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Ecancermedicalscience
Asıl Yazarlar: Bonadioa, Renata Colombo, Velho, Pedro Isaacsson, Marta, Guilherme Nader, Nardo, Mirella, Souza, Manoel Carlos LA, Muniz, David QB, Bezerra, Regis OF, Bispo, Raisa KA, Faraj, Sheila F, Bastos, Diogo A, Dzik, Carlos
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Cancer Intelligence 2019
Konular:
Research
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6946421/
https://ncbi.nlm.nih.gov/pubmed/31921344
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3332/ecancer.2019.973
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller